SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Amplatzer™ Talisman™ PFO Occluder

For Patent Foramen Ovale Closure

amplatzer occluder

Effective PFO Closure Made Easier1

Over 25 years ago, we pioneered PFO closure with the Amplatzer™ PFO Occluder. Today, it is the most-studied — and most-trusted — device of its kind, with over 180,000 patients treated worldwide.2

And our clinical evidence is unmatched, thanks to the largest-ever trial for PFO closure, boasting 5,810 patient-years of data.3


With the introduction of the Amplatzer Talisman PFO Occluder, we have built upon the proven Amplatzer PFO closure technology. The occluder now comes assembled and ready to use, simplifying prep and enhancing ease-of-use. And we've refined the 30mm size to have a smaller left atrial disc to better avoid interference with surrounding structures.

The easy-to-use just got easier.

Amplatzer Talisman PFO Occluder

Get the Amplatzer Portfolio App

The Amplatzer Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on respective Instructions for Use.
 

Download on the App Store badge
Download on the Apple App Store
Get on Google Play badge
Download on Google Play
Get the Amplatzer Portfolio App
Get the Amplatzer Portfolio App

Ordering Information

Sizing and Device Selection
Amplatzer™ Talisman™ PFO Occluder
Model/Reorder NumberRight Atrial Disc Diameter
A		Left Atrial Disc Diameter
B		Recommended Sheath Size
9-PFO-181818 mm18 mm8 F; 45° curve
9-PFO-251825 mm18 mm8 F; 45° curve
9-PFO-302530 mm25 mm9 F; 45° curve
9-PFO-352535 mm25 mm9 F; 45° curve

 

Amplatzer PFO
Delivery Sheath
Amplatzer™ Talisman™ Delivery Sheath
Model/Reorder NumberSheath SizeTip AngleSheath Inner DiameterSheath Outer DiameterUsable Length
9-TDS-08F45-808 F45°2.69 mm3.45 mm80 cm
9-TDS-09F45-809 F45°3.00 mm3.81 mm80 cm

 

Ancillary Products
Amplatzer™ Guidewire
Model/Reorder NumberDiameterBodyTip DescriptionUsable Length
9-GW-0020.035 inchSuper Stiff1.55 mm, Modified J-tip260 cm

 

Device Sizing Guidelines
PFO MorphologyExample Anatomical CharacteristicsSuggested Amplatzer Talisman PFO Occluder size (mm)
Simple PFO or PFO with a non-prominent ASA
PFO where a secure device position and effective PFO closure can be achieved when using the 25 mm device size
  1. Absence of ASA, long tunnel, and thickened septum secundum
  2. Non-prominent ASA (<20 mm total excursion) without a long tunnel (≥ 10 mm length) and without a thickened septum secundum (≥ 10 mm thickness)
25
Complex PFO
PFO with one or more anatomical characteristics that may complicate the ability to achieve a secure device position and effective PFO closure when using the 25 mm device size
  1. ASA (≥ 10 mm excursion) with long tunnel (≥ 10 mm length)
  2. ASA (≥ 10 mm excursion) with thickened septum secundum (≥ 10 mm thickness)
  3. Prominent ASA with excessive mobility (≥ 20 mm total excursion)
  4. Lipomatous hypertrophy of septum secundum (≥ 15 mm thickness)
30 or 35
PFO with small anatomy
Anatomy not suitable for 25 mm device size secondary to interference with adjacent cardiac structures
  1. Septal primum length < 20 mm
18

Note: Evaluate the position of the device after deployment, but before detachment. Use echocardiography to ensure that the device does not impinge on the free atrial wall or aortic root. If the device interferes with an adjacent cardiac structure (such as free atrial wall or aortic root), recapture the device and redeploy. If device position remains unsatisfactory, recapture the device and either replace with a smaller device (18 mm or 25 mm) or refer the patient for alternative treatment.

The presence of an ASA alone does not necessarily prevent successful PFO closure with a 25 mm device size. In RESPECT1, 180 patients (36%) in the device closure group had an ASA. The 25 mm device size was used in the majority of patients with an ASA (77%) to close the PFO, and at 6-months post-implant, effective closure was achieved in 95% of these patients. There were no cases of device embolization in any patient in the study

1. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022-32.
 
Amplatzer Amulet LAA

References

  1. Tests performed by and data on file at Abbott.
  2. Abbott data on file.
  3. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017; 377: 1022-32.

MAT-2010368 v3.0 | Item approved for OUS use only.

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0